Analyst Price Target is $9.00
▲ +322.54% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Forian in the last 3 months. The average price target is $9.00, with a high forecast of $13.00 and a low forecast of $5.00. The average price target represents a 322.54% upside from the last price of $2.13.
Current Consensus is
Buy
The current consensus among 3 investment analysts is to buy stock in Forian. This Buy consensus rating has held steady for over two years.
Forian Inc. provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition, the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc.
Read More
